Nitish Mehta1, Rosa Dolz Marco2, Raquel Goldhardt3, Yasha Modi1. 1. Department of Ophthalmology, New York University, New York, NY. 2. Vitreous Retina Macula Consultants of New York, New York, NY. 3. Bascom Palmer Eye Institute, Miami, Florida.
Abstract
PURPOSE OF REVIEW: This review will seek to answer if advances in ophthalmic imaging and evolution of treatment modalities have shed further light on the epidemiology, pathophysiology, diagnosis, and acute management of acute CRAO. RECENT FINDINGS: Imaging characteristics of acute CRAO have been further characterized with the use of fluorescein angiography, optical coherence tomography (OCT), OCT-angiography, and indocyanine-green angiography. Layer segmentation of OCT imaging has found inner retinal layer hyper-reflectivity to be a common finding in acute CRAO. Non-invasive therapies, fibrinolytic delivery, and surgical interventions for acute CRAO have been further evaluated as potential management tools. SUMMARY: A large body of literature reports very inconsistent treatment success with a wide variety of modalities. Currently, there is no clear evidence supporting the use of fibrinolytics in acute CRAO. Large, multicenter, randomized control trials are necessary to elucidate the role of the various acute treatment options in the management of CRAO.
PURPOSE OF REVIEW: This review will seek to answer if advances in ophthalmic imaging and evolution of treatment modalities have shed further light on the epidemiology, pathophysiology, diagnosis, and acute management of acute CRAO. RECENT FINDINGS: Imaging characteristics of acute CRAO have been further characterized with the use of fluorescein angiography, optical coherence tomography (OCT), OCT-angiography, and indocyanine-green angiography. Layer segmentation of OCT imaging has found inner retinal layer hyper-reflectivity to be a common finding in acute CRAO. Non-invasive therapies, fibrinolytic delivery, and surgical interventions for acute CRAO have been further evaluated as potential management tools. SUMMARY: A large body of literature reports very inconsistent treatment success with a wide variety of modalities. Currently, there is no clear evidence supporting the use of fibrinolytics in acute CRAO. Large, multicenter, randomized control trials are necessary to elucidate the role of the various acute treatment options in the management of CRAO.
Authors: Marco A Bonini Filho; Mehreen Adhi; Talisa E de Carlo; Daniela Ferrara; Caroline R Baumal; Andre J Witkin; Elias Reichel; Laura Kuehlewein; SriniVas R Sadda; David Sarraf; Jay S Duker; Nadia K Waheed Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Luca Rosignoli; Edward R Chu; John E Carter; Daniel A Johnson; Jeong-Hyeon Sohn; Sepehr Bahadorani Journal: Korean J Ophthalmol Date: 2021-11-08
Authors: Ramin Khoramnia; Marta S Figueroa; Lars-Olof Hattenbach; Carlos E Pavesio; Majid Anderesi; Robert Schmouder; Yu Chen; Marc D de Smet Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-12-21 Impact factor: 3.535